Control of erythropoietin production during hypoxic hypoxia.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D007611:Aprotinin / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004920:Erythropoiesis / Q000187:drug effects; D004921:Erythropoietin / Q000096:biosynthesis*; D005260:Female; D006498:Hepatectomy; D000860:Hypoxia / Q000503:physiopathology*; D008099:Liver / Q000502:physiology; D011480:Protease Inhibitors; D011691:Puromycin / Q000494:pharmacology; D051381:Rats
D000614:Aminocaproates; D000963:Antimetabolites; D011480:Protease Inhibitors; D004921:Erythropoietin; D003609:Dactinomycin; D011691:Puromycin; D007611:Aprotinin; D003513:Cycloheximide